The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

It’s Raining M&A: Update

Canadian developments first:

The committee is comprised of William Anderson, Robert Luba, James MacDonald and Gregory Spivy, each of whom is independent of management. James MacDonald will act as Chair of the committee. Goldman, Sachs & Co and RBC Capital Markets are assisting the Company and the Board of Directors as financial advisors.

DealBook has an interesting post talking about the Pfizer-Wyeth merger agreement, followed by some good comments.

Score one for the financial buyers: fourth time was a charm for Deerfield Capital, which signed a deal to buy NitroMed for $46 million (go-shop period through February 26)

Also in the (deal) pipeline:

Bookmark and Share

2 responses to “It’s Raining M&A: Update

  1. Pingback: M&A Update « The Cross-Border Biotech Blog

  2. Pingback: It Might Rain M&A at Merck Too « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 128 other followers